ReviewInfectious diseases of poverty2018
Toxocariasis: a silent threat with a progressive public health impact.
Review in Infectious diseases of poverty, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
102 citing papers in PubMed, 2 syntheses or guidelines pooled it, 262 citations in OpenAlex.
- Worldwide prevalence of protozoans and helminths among disabled people: a systematic review and meta-analysis.BMC public health · 2025Pooled it
- Seroprevalence of human toxocariasis in Latin America and the Caribbean: a systematic review and meta-analysis.Frontiers in public health · 2023Pooled it
- Article
- Recycling Workers: Food Insecurity as a Novel Associated Risk Factor for Toxocariasis.Pathogens (Basel, Switzerland) · 2026Article
- Seroprevalence and Risk Factors Associated with Anti-International journal of environmental research and public health · 2026Article
- Zoonotic Relevance ofPathogens (Basel, Switzerland) · 2026Article
- Insights into the seroprevalence ofOne health (Amsterdam, Netherlands) · 2026Article
- Pulmonary toxocariasis presenting as migratory pulmonary infiltrates and mediastinal lymphadenopathy: a case report and literature review.BMC pulmonary medicine · 2026Review
- Retinal Granuloma Progression After Scleral Buckling in Ocular Toxocariasis: A Case Report.The American journal of case reports · 2026Article
- Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stagesBiomedica : revista del Instituto Nacional de Salud · 2026Article
- Toxocariasis in immigrants and travelers with unexplained eosinophilia.Parasites & vectors · 2026Article
- Epidemiological study ofFrontiers in veterinary science · 2026Article
- Persistent eosinophilia following treatment for pediatric pyogenic liver abscess: A case report.SAGE open medical case reports · 2026Article
- Case Report: Toxocariasis as a rare trigger of vasculitis: a case-based review.Frontiers in immunology · 2026Review
- Beyond the clinical eye: mapping intestinal parasitic infections and its risk factors among dogs and cats across Portugal.Frontiers in veterinary science · 2026Article
- High toxocariasis seroprevalence in a tri-border indigenous community (Brazil, Paraguay and Argentina): A One Health perspective.One health (Amsterdam, Netherlands) · 2025Article
- Seroprevalence of Toxocara spp. infection and its associated factors among children in Vietnam: A cross-sectional study.Medicine · 2025Article
- Review
- First Report on the Seroprevalence and Risk Factors Associated withPathogens (Basel, Switzerland) · 2025Article
- Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review.International journal of molecular sciences · 2025Review
42 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 7 institutions in 4 countries.
Funding
Abstract
backgroundToxocariasis is a neglected parasitic zoonosis that afflicts millions of the pediatric and adolescent populations worldwide, especially in impoverished communities. This disease is caused by infection with the larvae of Toxocara canis and T. cati, the most ubiquitous intestinal nematode parasite in dogs and cats, respectively. In this article, recent advances in the epidemiology, clinical presentation, diagnosis and pharmacotherapies that have been used in the treatment of toxocariasis are reviewed. MAIN TEXT: Over the past two decades, we have come far in our understanding of the biology and epidemiology of toxocariasis. However, lack of laboratory infrastructure in some countries, lack of uniform case definitions and limited surveillance infrastructure are some of the challenges that hindered the estimation of global disease burden. Toxocariasis encompasses four clinical forms: visceral, ocular, covert and neural. Incorrect or misdiagnosis of any of these disabling conditions can result in severe health consequences and considerable medical care spending. Fortunately, multiple diagnostic modalities are available, which if effectively used together with the administration of appropriate pharmacologic therapies, can minimize any unnecessary patient morbidity.
conclusionsAlthough progress has been made in the management of toxocariasis patients, there remains much work to be done. Implementation of new technologies and better understanding of the pathogenesis of toxocariasis can identify new diagnostic biomarkers, which may help in increasing diagnostic accuracy. Also, further clinical research breakthroughs are needed to develop better ways to effectively control and prevent this serious disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.